Retargeting from the CR3 to the LFA-1 Receptor Uncovers the Adenylyl Cyclase Enzyme-translocating Segment of Adenylate Cyclase Toxin
Overview
Authors
Affiliations
The adenylate cyclase toxin-hemolysin (CyaA) and the α-hemolysin (HlyA) of belong to the family of cytolytic pore-forming Repeats in ToXin (RTX) cytotoxins. HlyA preferentially binds the αβ integrin LFA-1 (CD11a/CD18) of leukocytes and can promiscuously bind and also permeabilize many other cells. CyaA bears an N-terminal adenylyl cyclase (AC) domain linked to a pore-forming RTX cytolysin (Hly) moiety, binds the complement receptor 3 (CR3, αβ, CD11b/CD18, or Mac-1) of myeloid phagocytes, penetrates their plasma membrane, and delivers the AC enzyme into the cytosol. We constructed a set of CyaA/HlyA chimeras and show that the CyaC-acylated segment and the CR3-binding RTX domain of CyaA can be functionally replaced by the HlyC-acylated segment and the much shorter RTX domain of HlyA. Instead of binding CR3, a CyaA/HlyA chimera bound the LFA-1 receptor and effectively delivered AC into Jurkat T cells. At high chimera concentrations (25 nm), the interaction with LFA-1 was not required for CyaA/HlyA binding to CHO cells. However, interaction with the LFA-1 receptor strongly enhanced the specific capacity of the bound CyaA/HlyA chimera to penetrate cells and deliver the AC enzyme into their cytosol. Hence, interaction of the acylated segment and/or the RTX domain of HlyA with LFA-1 promoted a productive membrane interaction of the chimera. These results help delimit residues 400-710 of CyaA as an "AC translocon" sufficient for translocation of the AC polypeptide across the plasma membrane of target cells.
Ostolaza H, Amuategi J Int J Mol Sci. 2024; 25(6).
PMID: 38542105 PMC: 10970614. DOI: 10.3390/ijms25063131.
Structural basis for non-canonical integrin engagement by Bordetella adenylate cyclase toxin.
Goldsmith J, DiVenere A, Maynard J, McLellan J Cell Rep. 2022; 40(7):111196.
PMID: 35977491 PMC: 9416875. DOI: 10.1016/j.celrep.2022.111196.
Klimova N, Holubova J, Streparola G, Tomala J, Brazdilova L, Stanek O PLoS Pathog. 2022; 18(6):e1010577.
PMID: 35666769 PMC: 9216613. DOI: 10.1371/journal.ppat.1010577.
RtxA Cytotoxin in the Context of Other RTX Toxins.
Filipi K, Rahman W, Osickova A, Osicka R Microorganisms. 2022; 10(3).
PMID: 35336094 PMC: 8953716. DOI: 10.3390/microorganisms10030518.
Holubova J, Juhasz A, Masin J, Stanek O, Jurnecka D, Osickova A Int J Mol Sci. 2021; 22(21).
PMID: 34769101 PMC: 8583748. DOI: 10.3390/ijms222111655.